Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the […]
Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024
Weekly subcutaneous doses of pemvidutide resulted in robust reductions in cardio-inflammatory, hepato-inflammatory and atherosclerotic lipids Findings support the potential benefit […]
Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
BOSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the […]
Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
— Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of […]
TSX News -
Global Dividend Growth Split Corp. Renews At-The-Market Equity Program
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) […]
Kelly Named Corporation of the Year by National Minority Supplier Development Council
TROY, Mich., Nov. 15, 2024 (GLOBE NEWSWIRE) — Kelly has been named Corporation of the Year by the National Minority […]
TSX News -
Allied Announces November 2024 Distribution
TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have […]
Ingredion og Lantmännen inngår strategisk partnerskap for å akselerere utviklingen av plantebaserte proteiner
WESTCHESTER, Ill., Nov. 15, 2024 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), en ledende global leverandør av ingrediensløsninger til bruk […]
